Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2014
March 2014, Vol 5, No 2
March 2014, Vol 5, No 2
Promising New Therapies in the Breast Cancer Pipeline
By
Phoebe Starr
Value-Based Care
,
VBCC Perspectives
March 2014, Vol 5, No 2
San Antonio, TX—Many new drugs are currently in development for the treatment of patients with breast cancer. The following is a selection of drugs featured at the 2013 San Antonio Breast Cancer Symposium.
Read Article
Considering Prophylactic Salpingo-Oophorectomy in Women with BRCA Mutations
By
Jonathan S. Berek, MD, MMS
;
Allison W. Kurian, MD, MSc
Value-Based Care
,
VBCC Perspectives
March 2014, Vol 5, No 2
The study “Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation” that was recently published in the Journal of Clinical Oncology (Finch AP, et al. 2014 February 24 [Epub ahead of print]) provides an update of previous work by the same investigators on a similar population.
Read Article
ACA Heralds Modest Increase in Healthcare Utilization for Testicular Seminoma
By
Alice Goodman
Economics & Value
,
Economics of Cancer Care
March 2014, Vol 5, No 2
San Francisco, CA—Concerns that healthcare utilization will increase dramatically once more patients are insured under the Affordable Care Act (ACA) may be overblown, based on results of a large study of Medicaid and underinsured patients with seminoma, the most common type of testicular cancer.
Read Article
Switching from Intravenous to Subcutaneous Rituximab Saves Staff Time and Money
By
Wayne Kuznar
Economics & Value
,
Economics of Cancer Care
March 2014, Vol 5, No 2
New Orleans, LA—The efficiency of rituximab (Rituxan) and the associated cost can be improved by switching from intravenous (IV) to subcutaneous (SC) administration. Such a switch led to a substantial reduction in patient chair time and in active healthcare professional time, said Christof Wiesner, PhD, MPH, of the Market Access Department, Genentech, San Francisco, CA, at the ASH 2013 meeting.
Read Article
Systemic Therapy Wins One, Loses One in Head and Neck Cancer
By
Charles Bankhead
Head and Neck Cancer
March 2014, Vol 5, No 2
Scottsdale, AZ—The addition of chemotherapy to irradiation proved superior to accelerated radiotherapy without systemic therapy in a randomized trial of patients with advanced head and neck cancer.
Read Article
New Pathways, Targeted Therapies Being Explored in Hepatocellular Carcinoma
By
Wayne Kuznar
Pathways
,
Policies & Guidelines
March 2014, Vol 5, No 2
San Francisco, CA—Many molecularly targeted agents that inhibit different pathways of hepatocarcinogenesis are under development, and novel targets are being assessed in hepatocellular carcinoma (HCC), said Andrew X. Zhu, MD, PhD, Director, Liver Cancer Research, Massachusetts General Hospital, Boston, at the 2014 Gastrointestinal Cancers Symposium.
Read Article
Value Propositions
By
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
March 2014, Vol 5, No 2
Read Article
Is the Promise of Health Information Technology More than a Hope and a Prayer? This Year at HIMSS
By
Craig Deligdish, MD
From the Editor
,
Value Peer-spectives
March 2014, Vol 5, No 2
>At the end of February, I had the opportunity to attend the Healthcare Information and Management Systems Society (HIMSS)14 Annual Conference, which was held in Orlando, FL. Attended by more than 30,000 committed vendors, healthcare administrators, providers, politicians, scientists, and others, the meeting provided a great deal of insight into the health information community’s past accomplishments, the present state of the art, and expectations for the future.
Read Article
Genetic Test for Breast Cancer Screening Cost-Effective for Women at Intermediate Risk
By
Eileen Koutnik-Fotopoulos
Economics & Value
,
Economics of Cancer Care
March 2014, Vol 5, No 2
The American Cancer Society has recommended annual magnetic resonance imaging (MRI) as an adjunct to mammography for breast cancer screening in women who have a lifetime risk of breast cancer of approximately 25% to ?50%, as determined by models such as the Gail risk test. A new simulated clinical trial evaluated the cost-effectiveness of using 7 single-nucleotide polymorphisms (7SNPs) in combination with the Gail test to assess the cost-benefit of annual MRI screening in women at risk for breast cancer (Folse HJ, et al.
Cancer Prev Res [Phila]
. 2013;6:1328-1336).
Read Article
Outpatient Chemoradiation Regimen Matches Inpatient Care Outcomes, at Lower Costs
By
Charles Bankhead
Head and Neck Cancer
March 2014, Vol 5, No 2
Scottsdale, AZ—Definitive chemoradiation with single-agent outpatient chemotherapy for head and neck cancer led to disease control and survival equivalent to that of inpatient multi-agent therapy, at an annualized savings of almost $650,000, according to results of a small randomized trial presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma